Elderly donor liver transplantation
Elderly donor liver transplantation has been studied in 1 paper since 2026: 1 observational study in people; 1 in the past year. The newest paper, Oct 21, 2026: “Impact of Elderly Donors on Patient Survival and Postoperative Complications in Liver Transplantation: A Retrospective Study”.
1 paper studies it5 findingsUpdated
1 new paper in 30 daysSee all 1
“Overall survival (P = 0.681) and hepatocellular carcinoma disease-free survival (P = 0.486) were similar between groups.”
None of its findings points the other way.
- 1 lab in 1 country
- Humans1
What did studies of Elderly donor liver transplantation find?
2Studies of Elderly donor liver transplantation measured 2 outcomes; the most studied are hepatocellular carcinoma disease-free survival (1 study) and overall survival (1).
Hepatocellular carcinoma disease-free survival
no changein humans1
1 study
Hepatocellular carcinoma disease-free survival
no changein humans1
Elderly donor liver transplantation was not clearly linked with hepatocellular carcinoma disease-free survival in humans (Liver transplantation for hepatocellular carcinoma).
“Overall survival (P = 0.681) and hepatocellular carcinoma disease-free survival (P = 0.486) were similar between groups.”
HumansLiver transplantation for hepatocellular carcinomaliver
Transplantation direct
Overall survival
no changein humans1
1 study
Overall survival
no changein humans1
Elderly donor liver transplantation was not clearly linked with overall survival in humans (Deceased-donor liver transplantation).
“Overall survival (P = 0.681) and hepatocellular carcinoma disease-free survival (P = 0.486) were similar between groups.”
HumansDeceased-donor liver transplantationlivern = 950
Transplantation direct
What is Elderly donor liver transplantation linked with?
3Studies link Elderly donor liver transplantation with 3 measures, most often splenic artery steal syndrome (1 study), acute rejection (1) and primary nonfunction (1).
Splenic artery steal syndrome
upin humans1OR 5.881
1 study
Splenic artery steal syndrome
upin humans1OR 5.881
Elderly donor liver transplantation is associated with splenic artery steal syndrome in humans (Adjusted analysis following deceased-donor liver transplantation) (Adjusted OR 5.881, 95% CI 1.043–33.149; incidence 2.0% versus 0.5%).
“Elderly donor grafts were not associated with inferior long-term recipient survival but were associated with higher risks of PNF, AR, and SASS.”
HumansAdjusted analysis following deceased-donor liver transplantationlivern = 950
Transplantation direct
Acute rejection
upin humans1OR 5.314
1 study
Acute rejection
upin humans1OR 5.314
Elderly donor liver transplantation is associated with acute rejection in humans (Adjusted analysis following deceased-donor liver transplantation) (Adjusted OR 5.314, 95% CI 1.720–16.420; incidence 29.4% versus 10.9%).
“Elderly donor grafts were not associated with inferior long-term recipient survival but were associated with higher risks of PNF, AR, and SASS.”
HumansAdjusted analysis following deceased-donor liver transplantationlivern = 950
Transplantation direct
Primary nonfunction
upin humans1OR 3.199
1 study
Primary nonfunction
upin humans1OR 3.199
Elderly donor liver transplantation is associated with primary nonfunction in humans (Adjusted analysis following deceased-donor liver transplantation) (Adjusted OR 3.199, 95% CI 2.131–4.802; incidence 4.0% versus 0.9%).
“After adjustment, elderly donor status remained associated with PNF (odds ratio [OR], 3.199; 95% confidence interval [CI], 2.131-4.802)”
HumansAdjusted analysis following deceased-donor liver transplantationlivern = 950
Transplantation direct